Rhinitis, Allergic, Perennial News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

When battling allergies, your best weapon is identifying your problem allergen - STLtoday.com



When battling allergies, your best weapon is identifying your problem allergen 
STLtoday.com
Dear Dr. Roach ? I live in extreme northeast Texas, so allergies are a given. Every morning, 24/7/365, my nose runs. Sometimes hot liquid runs out of my nose before I can even grab a tissue. I have taken Allegra, Claritin, Xyzal, etc. Nothing seems to ...

and more » 


When battling allergies, your best weapon is first identifying your problem allergen - Sunbury Daily Item



When battling allergies, your best weapon is first identifying your problem allergen 
Sunbury Daily Item
DEAR DR. ROACH: I live in extreme northeast Texas, so allergies are a given. Every morning, 24/7/365, my nose runs. Sometimes hot liquid runs out of my nose before I can even grab a tissue. I have taken Allegra, Claritin, Xyzal, etc. Nothing seems to ...

 


Perennial Allergic Rhinitis ? Pipeline Review, H2 2016 - satPRnews (press release)



Perennial Allergic Rhinitis ? Pipeline Review, H2 2016 
satPRnews (press release)
Additionally, the report provides an overview of key players involved in therapeutic development for Perennial Allergic Rhinitis and features dormant and discontinued projects. The report features investigational drugs from across globe covering over ...

and more » 


Perennial Allergic Rhinitis ? Pipeline Review, H1 2016 - MilTech



satPRnews
 
Perennial Allergic Rhinitis ? Pipeline Review, H1 2016 
MilTech
Additionally, the report provides an overview of key players involved in therapeutic development for Perennial Allergic Rhinitis and features dormant and discontinued projects. Our report features investigational drugs from across globe covering over ...
Allergic Rhinitis Treatment Market: By Disease Type (Seasonal Allergic Rhinitis, Perenial Allergic Rhinitis) By ... satPRnews (press release)

all 5 news articles » 


ENT Disorder Treatment Market Landscape, Size and Forecast Analysis - GEOPOLMonitor



GEOPOLMonitor
 
ENT Disorder Treatment Market Landscape, Size and Forecast Analysis 
GEOPOLMonitor
Deteriorating environmental conditions is one of the major reasons for the rising prevalence of ENT disorders such as rhinitis. For instance, perennial allergic rhinitis can prevail around the year and is often the result of sensitivity to mold on ...

and more » 


Perennial Allergic Rhinitis Market: By Treatment (Steroids, Antihistamines), By Diagnosis (Radio Allergo Sorbent ... - satPRnews (press release)



Perennial Allergic Rhinitis Market: By Treatment (Steroids, Antihistamines), By Diagnosis (Radio Allergo Sorbent ... 
satPRnews (press release)
The rhinitis is one of the short term and environment related acute disease of the nasal system, in which irritation and inflammation of the internal lining and mucous membrane of the nose occurs. Globally, development of new and more effective ...

 


Ipca Laboratories acquires US pharma manufacturer for $9.65 mln - Ultra News



Ipca Laboratories acquires US pharma manufacturer for $9.65 mln 
Ultra News
Ipca Laboratories Ltd said it is has acquired US-based drug manufacturer Pisgah Labs Inc. for US$ 9.65 millions free of debt. The acquisition is aimed at establishing the company's foothold in the US market in the field of contract research and small ...

and more » 


Aurobindo Pharma gets USFDA nod for generic deep vein thrombosis drug - Ultra News



Ultra News
 
Aurobindo Pharma gets USFDA nod for generic deep vein thrombosis drug 
Ultra News
Aurobindo Pharma Limited said it received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Fondaparinux Sodium injection ? a bioequivalent and therapeutic equivalent to Arixtra of Mylan Ireland. The product, used ...

and more » 


Positive Phase III results for Ryaltris in perennial allergic rhinitis - The Pharma Letter



The Pharma Letter
 
Positive Phase III results for Ryaltris in perennial allergic rhinitis 
The Pharma Letter
In a Phase III study evaluating the safety of Ryaltris (mometasone furoate 25mcg) and olopatadine hydrochloride 665mcg), an investigational fixed-dose combination nasal spray, in perennial allergic rhinitis (PAR), the drug met its primary clinical ...
Glenmark to file first specialty product with US FDA in March quarter Livemint

all 2 news articles » 


Toll Like Receptor 8 (CD288 or TLR8) ? Pipeline Review, H1 2017 - MilTech



Toll Like Receptor 8 (CD288 or TLR8) ? Pipeline Review, H1 2017 
MilTech
Report covers products from therapy areas Oncology, Immunology, Infectious Disease, Dermatology, Gastrointestinal, Respiratory and Musculoskeletal Disorders which include indications Actinic (Solar) Keratosis, Cutaneous T-Cell Lymphoma, Solid Tumor ...

and more »